When we analyzed the immune landscape of the primary tumors, we detected higher numbers of CD8+ TILs in the tumor periphery of stage T1N0M1 ccRCCs than stage T1N0M0 ccRCCs as a possible indication for a more aggressive tumor behavior. This evidence concerns the gene CD8A and neoplasm.